The Association Between Genetic Polymorphisms of Transporter Genes and Prognosis of Platinum-Based Chemotherapy in Lung Cancer Patients
Jia He,1,2 Zhan Wang,3 Ting Zou,4 Ying Wang,5 Xiang-Ping Li,1,2 Juan Chen1,2 1Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, 410008, People's Republic of China; 2National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University,...
Saved in:
Main Authors: | He J (Author), Wang Z (Author), Zou T (Author), Wang Y (Author), Li XP (Author), Chen J (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effects of WISP1 Polymorphisms on the Prognosis of Lung Cancer Patients with Platinum-Based Chemotherapy
by: He J, et al.
Published: (2021) -
The Association Between Heat-Shock Protein Polymorphisms and Prognosis in Lung Cancer Patients Treated With Platinum-Based Chemotherapy
by: Ting Zou, et al.
Published: (2020) -
Genetic Variants in Double-Strand Break Repair Pathway Genes to Predict Platinum-Based Chemotherapy Prognosis in Patients With Lung Cancer
by: Jun-Yan Liu, et al.
Published: (2022) -
Genetic Polymorphisms and the Efficacy of Platinum-Based Chemotherapy: Review
by: Afifah NN, et al.
Published: (2020) -
Non-Coding RNA Polymorphisms (rs2910164 and rs1333049) Associated With Prognosis of Lung Cancer Under Platinum-Based Chemotherapy
by: Yi-Xin Chen, et al.
Published: (2021)